Sort
21,281 grants matching “influenza”
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,258,384Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$1,256,929Bernard Moss · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Advanced Development of Vaccines for Influenza
$1,256,003Uwe Staerz · Greffex, Inc. · N01 · FY2024 · AI
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination
$1,255,141Mark M Davis · Stanford University · U19 · FY2018 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,254,364Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$1,253,062Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2006 · AI
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,252,072Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Development of a novel adjuvant for vaccine sparing
$1,250,865Sara Lustigman · New York Blood Center · R01 · FY2016 · AI
Neuronal pathogenesis: acute and post-acute implications of viruses
$1,250,286Rahul Suryawanshi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,250,000John Christian Victor · Path · U01 · FY2013 · IP
ADDRESSING EMERGING INFECTIOUS DISEASES IN THE REPUBLIC OF INDIA: INFLUENZA DISEA
$1,250,000Akilesh C Mishra · Indian Council Of Medical Research · U01 · FY2009 · IP
Strengthening Evidence-based Advocacy for Influenza Prevention and Control in India.
$1,250,000Anand Krishnan · All-India Institute Of Medical Sciences · U01 · FY2019 · IP
Strengthening Evidence-based Advocacy for Influenza Prevention and Control in India.
$1,250,000Anand Krishnan · All-India Institute Of Medical Sciences · U01 · FY2021 · IP
Influenza Immunization of Children in India
$1,250,000Wayne M Sullender · University Of Colorado Denver · U01 · FY2012 · IP
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$1,250,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2019 · IP
Strengthening Evidence-based Advocacy for Influenza Prevention and Control in India.
$1,250,000Anand Krishnan · All-India Institute Of Medical Sciences · U01 · FY2017 · IP
MOSAIC: Mobile Surveillance for ARI and ILI in the Community
$1,250,000Melissa S Stockwell · Columbia University Health Sciences · U01 · FY2014 · IP
Influenza Immunization of Children in India
$1,250,000Wayne M Sullender · University Of Colorado Denver · U01 · FY2013 · IP
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,250,000John Christian Victor · Path · U01 · FY2012 · IP
SBIR Phase II: Development of an Intracellular Delivery Platform for Accelerated Drug Discovery Using Genetically Engineered Human Immune Cells
$1,249,996Marija Tadin-Strapps · Sqz Biotechnologies Company · · FY2016 · TIP
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$1,249,833Anice Lowen · Emory University · N01 · FY2024 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation of a Natural History Challenge Study for Influenza
$1,249,595Robert Frenck · Cincinnati Childrens Hosp Med Ctr · N01 · FY2019 · AI
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
$1,249,427Harold A Chapman · University Of California, San Francisco · U01 · FY2018 · HL
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,249,339John Christian Victor · Path · U01 · FY2011 · IP
Automated Near-Patient Molecular Diagnostics and Discrimination of Seasonal Infl
$1,249,116Shuqi Chen · Iquum, Inc. · R44 · FY2010 · AI